Filling the need for trusted information on national health issues

Novel Financing Mechanisms Needed To Improve Access To Multidrug-Resistant TB Treatment

PLOS Medicine: Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
Thomas Hwang of Harvard University and the Blackstone Group, and Salmaan Keshavjee of Harvard University and Partners in Health, explore issues surrounding scaling up access to treatment for multidrug-resistant tuberculosis, including novel financing structures (9/30).